LakeShore Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 15, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	3	47	136	149	233	-
Market Cap Growth	-93.11%	-65.52%	-8.94%	-36.18%	-	-
Enterprise Value	56	71	176	408	373	-
Last Close Price	0.07	2.45	7.20	16.00	67.97	-
PS Ratio	0.03	0.55	1.71	1.49	2.94	-
PB Ratio	0.04	0.68	1.67	1.40	2.20	-
P/TBV Ratio	0.05	0.80	1.91	1.57	-	-
EV/Sales Ratio	0.66	0.84	2.22	4.08	4.70	-
Debt / Equity Ratio	0.83	0.83	0.73	0.69	0.57	0.02
Net Debt / Equity Ratio	0.77	0.77	0.30	0.18	0.16	-0.48
Net Debt / EBITDA Ratio	-29.89	-29.89	-0.56	-1.37	-1.32	3.80
Net Debt / FCF Ratio	-2.89	-2.89	-0.52	-0.55	-0.23	1.06
Asset Turnover	0.43	0.43	0.36	0.44	0.39	-
Inventory Turnover	0.50	0.50	0.94	0.83	0.90	-
Quick Ratio	0.64	0.64	0.86	1.27	1.23	1.84
Current Ratio	1.02	1.02	1.13	1.57	1.61	2.13
Return on Equity (ROE)	-18.43%	-18.43%	-65.99%	-40.50%	-32.69%	-
Return on Assets (ROA)	-2.15%	-2.15%	-13.85%	-5.17%	-5.46%	-
Return on Capital Employed (ROCE)	-9.10%	-9.10%	-50.40%	-12.30%	-11.80%	-15.30%
Earnings Yield	-498.99%	-29.47%	-44.28%	-27.72%	-16.00%	-
FCF Yield	-667.22%	-39.41%	-34.68%	-23.00%	-31.70%	-
Buyback Yield / Dilution	-89.94%	-79.18%	-73.06%	0.07%	-	-